Robert Morlock1, Amy Morlock2, Martha Downen3, Sonali N Shah4. 1. YourCareChoice, Ann Arbor, Michigan, United States of America. 2. Acumen Health Research Institute, Ann Arbor, Michigan, United States of America. 3. Downen Consulting Group, LLC, Rye, New York, United States of America. 4. Independent Scholar, Freehold, New Jersey, United States of America.
Abstract
BACKGROUND: Early recognition of COVID-19 cases is essential for effective public health measures aimed at isolation of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). The objective of this study was to describe characteristics, self-reported symptoms, and predictors of testing positive for SARS-CoV-2 infection in a community-based sample. METHODS AND FINDINGS: This was a cross-sectional nationwide survey of adults in the US conducted between April 24 through May 13, 2020. The survey targeted a representative sample of approximately 5,000 respondents. The rate of COVID-19 cases and testing, most frequently reported symptoms, symptom severity, treatment received, impact of COVID-19 on mental and physical health, and factors predictive of testing positive were assessed. Most of the 5,203 participants (85.6%) reported no COVID-19-like symptoms. Of the 747 (14.5%) participants reporting COVID-19-like symptoms, 367 (49.1%) obtained a diagnostic test. Eighty-nine participants (24.3%) reported a positive COVID-19 test result, representing 1.7% of the total sample. For those testing positive, the most common symptoms were dry cough, fever, and shortness of breath/difficulty breathing. Those who tested positive were more likely to report greater symptom severity versus those who tested negative. Severe dry cough, new loss of taste or smell, trouble waking up, living with someone experiencing symptoms, recent international travel, respiratory issues, and reporting ethnicity of Black or African American were predictive of testing positive. CONCLUSIONS: This study assessed the impact of COVID-19 using community-level self-reported data across the US during the peak of most stay at home' orders. Self-reported symptoms and risk factors identified in this study are consistent with the clinical profile emerging for COVID-19. In the absence of widespread testing, this study demonstrates the utility of a representative US community-based sample to provide direct-reported symptoms and outcomes to quickly identify high-risk individuals who are likely to test positive and should consider taking greater precautions.
BACKGROUND: Early recognition of COVID-19 cases is essential for effective public health measures aimed at isolation of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). The objective of this study was to describe characteristics, self-reported symptoms, and predictors of testing positive for SARS-CoV-2 infection in a community-based sample. METHODS AND FINDINGS: This was a cross-sectional nationwide survey of adults in the US conducted between April 24 through May 13, 2020. The survey targeted a representative sample of approximately 5,000 respondents. The rate of COVID-19 cases and testing, most frequently reported symptoms, symptom severity, treatment received, impact of COVID-19 on mental and physical health, and factors predictive of testing positive were assessed. Most of the 5,203 participants (85.6%) reported no COVID-19-like symptoms. Of the 747 (14.5%) participants reporting COVID-19-like symptoms, 367 (49.1%) obtained a diagnostic test. Eighty-nine participants (24.3%) reported a positive COVID-19 test result, representing 1.7% of the total sample. For those testing positive, the most common symptoms were dry cough, fever, and shortness of breath/difficulty breathing. Those who tested positive were more likely to report greater symptom severity versus those who tested negative. Severe dry cough, new loss of taste or smell, trouble waking up, living with someone experiencing symptoms, recent international travel, respiratory issues, and reporting ethnicity of Black or African American were predictive of testing positive. CONCLUSIONS: This study assessed the impact of COVID-19 using community-level self-reported data across the US during the peak of most stay at home' orders. Self-reported symptoms and risk factors identified in this study are consistent with the clinical profile emerging for COVID-19. In the absence of widespread testing, this study demonstrates the utility of a representative US community-based sample to provide direct-reported symptoms and outcomes to quickly identify high-risk individuals who are likely to test positive and should consider taking greater precautions.
Authors: Neil P Walsh; Michael Gleeson; Roy J Shephard; Maree Gleeson; Jeffrey A Woods; Nicolette C Bishop; Monika Fleshner; Charlotte Green; Bente K Pedersen; Laurie Hoffman-Goetz; Connie J Rogers; Hinnak Northoff; Asghar Abbasi; Perikles Simon Journal: Exerc Immunol Rev Date: 2011 Impact factor: 6.308
Authors: Fiona P Havers; Carrie Reed; Travis Lim; Joel M Montgomery; John D Klena; Aron J Hall; Alicia M Fry; Deborah L Cannon; Cheng-Feng Chiang; Aridth Gibbons; Inna Krapiunaya; Maria Morales-Betoulle; Katherine Roguski; Mohammad Ata Ur Rasheed; Brandi Freeman; Sandra Lester; Lisa Mills; Darin S Carroll; S Michele Owen; Jeffrey A Johnson; Vera Semenova; Carina Blackmore; Debra Blog; Shua J Chai; Angela Dunn; Julie Hand; Seema Jain; Scott Lindquist; Ruth Lynfield; Scott Pritchard; Theresa Sokol; Lynn Sosa; George Turabelidze; Sharon M Watkins; John Wiesman; Randall W Williams; Stephanie Yendell; Jarad Schiffer; Natalie J Thornburg Journal: JAMA Intern Med Date: 2020-07-21 Impact factor: 21.873
Authors: Jonathan M Wortham; James T Lee; Sandy Althomsons; Julia Latash; Alexander Davidson; Kevin Guerra; Kenya Murray; Emily McGibbon; Carolina Pichardo; Brian Toro; Lan Li; Marc Paladini; Meredith L Eddy; Kathleen H Reilly; Lisa McHugh; Deepam Thomas; Stella Tsai; Mojisola Ojo; Samantha Rolland; Maya Bhat; Katherine Hutchinson; Jennifer Sabel; Seth Eckel; Jim Collins; Catherine Donovan; Anna Cope; Breanna Kawasaki; Sarah McLafferty; Nisha Alden; Rachel Herlihy; Bree Barbeau; Angela C Dunn; Charles Clark; Pamela Pontones; Meagan L McLafferty; Dean E Sidelinger; Anna Krueger; Leslie Kollmann; Linnea Larson; Stacy Holzbauer; Ruth Lynfield; Ryan Westergaard; Richard Crawford; Lin Zhao; Jonathan M Bressler; Jennifer S Read; John Dunn; Adele Lewis; Gillian Richardson; Julie Hand; Theresa Sokol; Susan H Adkins; Brooke Leitgeb; Talia Pindyck; Taniece Eure; Karen Wong; Deblina Datta; Grace D Appiah; Jessica Brown; Rita Traxler; Emilia H Koumans; Sarah Reagan-Steiner Journal: MMWR Morb Mortal Wkly Rep Date: 2020-07-17 Impact factor: 17.586
Authors: Mark W Tenforde; Erica Billig Rose; Christopher J Lindsell; Nathan I Shapiro; D Clark Files; Kevin W Gibbs; Matthew E Prekker; Jay S Steingrub; Howard A Smithline; Michelle N Gong; Michael S Aboodi; Matthew C Exline; Daniel J Henning; Jennifer G Wilson; Akram Khan; Nida Qadir; William B Stubblefield; Manish M Patel; Wesley H Self; Leora R Feldstein Journal: MMWR Morb Mortal Wkly Rep Date: 2020-07-03 Impact factor: 17.586
Authors: Mohammed Iddir; Alex Brito; Giulia Dingeo; Sofia Sosa Fernandez Del Campo; Hanen Samouda; Michael R La Frano; Torsten Bohn Journal: Nutrients Date: 2020-05-27 Impact factor: 5.717
Authors: Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed Journal: Chem Senses Date: 2022-01-01 Impact factor: 3.160
Authors: Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed Journal: medRxiv Date: 2021-10-09
Authors: Randi K Johnson; Katie M Marker; Jan T Lowery; Christopher R Gignoux; David Mayer; Jonathan Shortt; David Kao; Kathleen C Barnes Journal: JMIR Public Health Surveill Date: 2022-06-13
Authors: Jean M Cox-Ganser; Paul K Henneberger; David N Weissman; Garret Guthrie; Caroline P Groth Journal: Am J Ind Med Date: 2022-07-05 Impact factor: 3.079
Authors: Richard Matzopoulos; Robert Morlock; Amy Morlock; Bernard Lerer; Leonard Lerer Journal: Front Psychiatry Date: 2022-01-03 Impact factor: 4.157